Skip to main content
DS

DASI Simulations

DASI Simulations offers an AI-powered platform that generates patient-specific cardiac simulations for structural heart disease procedures. This technology provides predictive visualization and automated assessments of device-anatomy interactions, enabling interventional cardiologists to optimize surgical planning and improve patient outcomes.

Dublin, United StatesFounded 2019292K+ followers
Updated 4 months ago

Funding

$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current pre-surgical planning for structural heart disease procedures often relies on manual analysis of medical imaging, which is time-consuming and prone to human error. This can lead to suboptimal device selection and placement, increasing the risk of complications such as device-related issues, abnormal blood flow, and adverse patient outcomes.

Solution

DASI Simulations provides an AI-powered computational predictive modeling platform that generates patient-specific cardiac simulations for interventional cardiologists. By analyzing CT angiograms, our proprietary technology simulates device-anatomy interactions, offering predictive visualization and automated assessments to guide optimal surgical planning. This approach aims to reduce procedural risks, enhance patient safety, and improve overall treatment efficacy for structural heart disease. Our platform also includes personalized support from biomedical engineers to ensure comprehensive decision-making.

Target Audience

The primary target audience includes interventional cardiologists, cardiac surgeons, and healthcare institutions focused on structural heart disease treatment.

Features

  • AI-driven computational predictive modeling for patient-specific cardiac simulations.
  • Predictive visualization of device-anatomy interactions to anticipate procedural outcomes.
  • Automated AI-based assessments for enhanced accuracy, repeatability, and reproducibility.
  • Cloud-based platform for secure upload of CT angiograms and simulation execution.
  • Interactive content generated from simulations to guide physician decision-making.
  • On-demand support from qualified biomedical engineers for quality checks and consultations.
  • Focus on structural heart disease procedures, including Transcatheter Aortic Valve Implantation (TAVI).
  • Publications in peer-reviewed journals demonstrating the efficacy of predictive modeling for TAVR complications.
This profile is AI-generated and may contain inaccuracies.